Olon is a global leader in the development and production of APIs for CDMOs and generics, supplying more than 300 APIs globally. Based near Milan, Italy, Olon maintains 11 facilities across Europe, North America, and Asia. The company provides an integrated suite of chemical synthesis and biological processing services to manage drug manufacturing projects in full regulatory compliance. Their robust API portfolio consists of regular potency and high potency APIs, and they offer additional analytical and technical capabilities to CDMOs.
